藤田医科大学 国際再生医療センター

研究トピックス
Research topics

発表論文

2025年度

1.Takahashi M.Four decades of the RET gene: From discovery to tumor-agnostic therapy Journal of the Formosan Medical
   Association
124: 895-901. (2025)

2.Iida M, Tanaka M, Takagi T, Matsuki T, Kimura K, Shibata, K, Kobayashi Y, Mizutani Y, Kuwamura H, Yamada K, Kitaura H,
       Kakita A, Sakakibara M, Asai N, Takahashi M, and Asai M. Girdin deficiency causes developmental and
    epileptic encephalopathy with hippocampal sclerosis and interneuronopathy 
Epilepsia. 66: 599-617. (2025)

3Mihara K(10人省略、8番目). A novel method for generating chimeric antigenreceptor-transduced primary human natural
  killer cells by the use of multiple cytokines
and anti-CD2 and anti-NKp46 stimulatory antibodies.  
  Biomed Pharmacother. 2025 191:118505.

4. Mihara K(21人省略、13番目). Monoallelic mutations in MMD2 cause autosomal  dominant aggressive periodontitis.
  J Exp Med. 2025 222(9):e20231911.

5. Mihara K(13人省略、12番目). Chimeric PD‑1 receptor redirects primary T cells  against childhood solid tumors but not to
  PD‑1 ligand‑positive CD80‑coexpressing
cells. Mol Med Rep. 2025 32(3):243.

6. Mihara K(5人省略、1番目). The Real World Impact of Immunoglobulin Replacement Therapy on Severe Bacterial
  Infection for Patients With Hypogammaglobulinemia
Secondary to Hematologic Malignancies: A Japanese
  Claims Database Study.
EJHaem. 2025 6(4):e70091. 

7. Mihara K(6人省略、5番目). Lipid-siRNA Conjugates Targeting High PD-L1 Expression as Potential Novel
  Immune Checkpoint Inhibitors.
Biomolecules. 2025 15(2):293.

2024年

1.  Watanabe K, Chiu H, Anderson DJ Whole-brain in situ mapping of neuronal activation in Drosophila during social
behaviors and optogenetic stimulation.eLife. 12: RP92380. (2024).

2.Kubo T, Yanagihara K, Nishimura Y, Iino Y, Komatsu T, Tansou R, Mihara K, Seyama T. Antitumor Effect of Oleoyl-siRNA against Pancreatic Cancer Using a Portal Vein Infusion Liver-Metastatic Mouse Model. 
Mol Pharm. 221: 5115-5125. (2024)

3.Kawamoto H, Kawase T, Nagano S. [Development of off-the-shelf universal T cell therapies from ES/iPS cells: applications in cancer and viral infection]. 
Rinsho Ketsueki. 65: 1075-1086. (2024)

4.Abe-Chayama H, Kawase T, Ichinohe T, Ishida Y, Tateno C, Hijikata M, Chayama K. Hepatitis B virus-specific human stem cell memory T cells differentiate into cytotoxic T cells and eradicate HBV-infected hepatocytes in mice. 
FEBS Lett. 598: 1354-1365. (2024)

5.Naoi H, Suzuki Y, Miyagi A, Horiguchi R, Aono Y, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Mii S, Ichihara M, Takahashi M, Suda, T. 
CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-b Signaling.  J Immunol. 212: 1221-1231. (2024)

6.  Ando R, Shiraki Y, Miyai Y, Shimizu H, Furuhashi K, Minatoguchi S, Kato K, Kato A, Iida T, Mizutani Y, Ito K, Asai N, Mii S, Esaki N, Takahashi M, Enomoto A.
Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas. J Pathol. 262: 61-75. (2024)

7.Owaki T, Iida T, Miyai Y, Kato K, Hase T, Ishii M, Ando R, Hinohara K, Akashi T, Mizutani Y, Ishikawa T, Mii S, Shiraki Y, Esaki N, Yamamoto M, Tsukamoto T, Nomura S, Murakami T, Takahashi M, Yuguchi Y et al. 
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
Brit J Cancer. 131: 372-386. (2024)

2023年

. Ando1 R, Shiraki Y, Miyai Y, Shimizu H, Furuhashi K, Minatoguchi S, Kato K, Kato A, Iida T, Mizutani Y, Ito K, Asai N, Mii S,
     EsakiiEsaki N, Takahashi M, Enomoto A.
     Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas.
     J Pathol. in press (2023)

2.Takahashi M. RET proto-oncogene.
      Molecular Diagnostics of Cancer (Intechopen) Editor: Dr. Pier Paolo Piccaluga

3.Mori N, Esaki N, Shimoyama Y, Shiraki Y, Asai N, Sakai T, Nishida Y, Takahashi M, Enomoto A, Mii S.
Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.
Pathol Res Pract. 245:154443. (2023)

4.Aono Y, Suzuki Y, Horiguchi R, Inoue Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Mii S, Takahashi M, Suda T.
CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation. Am J Respir Cell Mol Biol. 68:201-212. (2023)

5Sato T, Yamanaka Y, Ueno M, Sotozono C. Extra Eyelid-Derived Muscle Stem Cells. Methods Mol Biol. 2640:13-19. (2023)

6. Imai H, Kawase T, Yoshida S, Mese T, Roh S, Fujita A, Uchiki T, Sasaki A, Nagamatsu S, Takazawa A, Ichinohe T, Koshima I.
  Peripheral T cell profilingreveals downregulated exhaustion marker and increased diversity in lymphedema post-lymphatic
  venous anastomosis. iScience.
2023;26(6):106822.

7.  Ito Y, Yamagata M, Yamamoto Y, Hirasaka K, Nikawa T, Sato T.
     The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle  atrophy.
     eLife, 12:RP89381.doi:10.7554/eLife.89381.(2023)

8.Iriyama C(15人省略, 1番目), Goto N(5番目), Mihara K(8番目), Miyama T(9番目), Tomita A(19番目). Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases. Cancer Med. 2023 12(16):16972-16984. 

2022年

1.  Okamoto A,Fujigaki H,Iriyama C, Goto N, Yamamoto H, Mihara K, Inaguma Y, Miura  
Y, Furukawa K, Yamamoto Y, Akatsuka Y, Kasahara S, Miyao K, Tokuda M, Sato S,  
Mizutani Y, Osawa M,Hattori K,Iba S, Kajiya R, Okamoto M, Saito K. and Tomita A.
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after 
vaccination in B-cell lymphoma. Blood Adv. 6: 3230-3233 (2022).

2.  Iida T, Mizutani Y, Esaki N, Ponik S.M, Burkel B.M, Weng L, Kuwata K, Masamune A,
Ishihara S, Haga H, Kataoka K, Mii S, Shiraki Y, Ishikawa T, Ohno E,  

Kawashima H, Hirooka Y, Fujishiro M, Takahashi M. and Enomoto A.
Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to 
an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics.Oncogene 41: 2764-2777 (2022). 

3.  Miyai Y, Sugiyama D, Hase T, Asai N, Taki T, Nishida K, Fukui T, Chen-Yoshikawa 
T.F, Kobayashi H, Mii S, Shiraki Y, Hasegawa Y, Nishikawa H, Ando Y, Takahashi M. 
and Enomoto A.Meflin-positive cancer-associated fibroblasts enhance tumor response to
immune checkpoint blockade.Life Sci Alliance. 5: e202101230 (2022).

4.  Takahashi M.RET receptor signaling: Function in development, metabolic disease and cancer.Proc. Japan Acad. Ser. B 98: 112-125. (2022).

5.  Kobayashi H, Gieniec K.A, Lannagan T.R.M, Wang T, Asai N, Mizutani Y, Iida T, Ando R, 
Thomas E.M, Sakai A,Suzuki N, Ichinose M, Wright J.A, Vrbanac L, Ng J.Q, Goyne J,
Radford G, Lawrence M.J, Sammour T, Hayakawa Y, Klebe S, Shin A.E, Asfaha S, Bettington M.L,
Rieder F., Arpaia N, Danino T, Butler L.M, Burt A.D, Leedham S.J, Rustgi A.K, 
Mukherjee S, Takahashi M,
Wang T.C, Enomoto A, Woods S.L. and Worthley D.L.The Origin 
and Contribution of Cancer-Associated Fibroblasts in
Colorectal 
Carcinogenesis.Gastroenterology 162: 890-906. (2022).

6. Ichihara R, Shiraki Y, Mizutani Y, Iida T, Miyai Y, Esaki N, Kato A, Mii S, Ando R, 
Hayashi M, Takami H, Fujii T, Takahashi M. and Enomoto A.Matrix remodeling-associated 
protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer.Pathol Int. 72: 161-175. (2022).

7. Sawada A, Yamamoto T. and Sato T. Tceal5 and Tceal7 Function in C2C12 Myogenic 
Differentiation via Exosomes in Fetal Bovine Serum Int. J. Mol. Sci. 23: 2036 (2022).

8. Igarashi J, Niwa Y. and Sugiyama D.Research and development of oligonucleotide
therapeutics in Japan for rare diseases.Future Rare Dis. 2: 0008 (2022). 

9. Igarashi J., Niwa Y, Sugiyama D Current Opinion on Oligonucleotide Therapeutics for 
Allergy J Allergy Ther, Vol.13 Iss.5 No:1000285. (2022)

10.Iriyama C(8人省略、3番目), Goto N(4番目), Miyama T(9番目), Mihara K(10番目), Tomita A(12番目).
 Acute fulminant intravascular hemolysis induced by Clostridium perfringens in a 
symptomatic multiple myeloma patient
 under immuno-chemotherapy. Ann Hematol. 2022 
101(12):2813-2815.

11. Mihara K(16人省略、14番目). NKp44-based chimeric antigen receptor effectively redirects 
  primary T cells against synovial sarcoma. Transl Oncol. 2022 25:101521.

12. Mihara K(5人省略、4番目). Elevated METTL9 is associated with peritoneal dissemination 
  in human scirrhous gastric cancers. Biochem Biophys Rep. 2022 30:101255.

13. Okamoto A, Fujigaki H, Iriyama C, Goto N, Yamamoto H, Mihara K, Inaguma Y, Miura Y, 
  Furukawa K, Yamamoto Y, Akatsuka Y, Kasahara S, Miyao K, Tokuda M, Sato S, Mizutani Y, 
  Osawa M, Hattori K, Iba S, Kajiya R, Okamoto M, Saito K, Tomita A. CD19-positive 
  lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination 
  in B-cell lymphoma. Blood Adv. 2022 Jun 14;6(11):3230-3233. doi: 10.1182/bloodadvances.2021006302.PMID: 35026843; PMCID: PMC8759802.

 

2021年

1. Takahashi M., Kobayashi H., Mizutani Y., Hara A., Iida T., Miyai Y., Asai N., Enomoto A.
    Roles of the mesenchymal stromal/stem cell marker Meflin/Islr in cancer fibrosis.
    Front. Cell Dev. Biol. 9:749924 (2021).
 
2. Ozono Y., Tamura A., Nakayama S., Herawati E., Hanada Y., Ohata K., Takagishi M., Takahashi M., Imai T., Ohta Y., Oshima K.,
    Sato T., Inohara H. and Tsukita S.
    Daple deficiency causes hearing loss in adult mice by inducing defects in cochlear stereocilia and apical microtubules.
    Sci. Rep. 11: 20224 (2021).
 
3. Kobayashi H., Gieniec K.A., Ng, J.Q., Goyne, J., Lannagan, T.R.M., Thomas, E.M., Radford, G., Wang, T., Suzuki, N., Ichinose, M.,
    Wright, J.A., Vrbanac, L., Burt, A.D., Takahashi, M., Enomoto, A.,
    Worthley, D.L. and Woods, S.L.
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma.
    J. Vis. Exp. Sep 3;(175) (2021).  

4. Yasuda Y., Iwama S., Sugiyama D., Okuji T., Kobayashi T., Ito M., Okada N., Enomoto A., Ito S., Yan Y., Sugiyama M., Onoue T.,
    Tsunekawa T., Ito Y., Takagi H., Hagiwara D., Goto M., Suga H., Banno R.,Takahashi M., Nishikawa H. and Arima H.
    CD4+ T cells are essential for the development of destructive thyroiditis induced by anti-PD-1 antibody in
    thyroglobulin-immunized mice.
    Sci. Transl. Med. 13: eabb7495 (2021).

5. Nakahara Y., Hashimoto N., Sakamoto K., Enomoto A., Adams T.S., Yokoi T., Omote N., Poli S., Ando A., Wakahara K., Suzuki A.,
    Inoue M., Hara A., Mizutani Y., Imaizumi K., Kawabe T., Rosas I.O., Takahashi M., Kaminski N. and Hasegawa Y.
  Fibroblasts positive for meflin have anti-fibrotic property in pulmonary fibrosis.
  Eur. Resp. J. 58: 2003397. (2021).
 
6. Hara A., Kato K., Ishihara T., Kobayashi H., Asai N., Mii S., Shiraki Y., Miyai Y., Ando r., Mizutani Y., Iida T., Takefuji M.,
    Murohara T.,Takahashi M. and Enomoto A.
  Meflin defines mesenchymal stem cells and early progenitors with multilineage differentiation capacity across multiple tissues.
  Genes Cells 26: 495-512. (2021)
 
7. Nakayama S., Yano T., Namba T., Konishi S., Takagishi M., Herawati E., Nishida T., Imoto Y., Ishihara S., Takahashi M., Furuta K.,
    Oiwa K., Tamura A. and Tsukita S.
  Planar cell polarity induces local microtubule bundling for coordinated ciliary beating.
  J. Cell Biol. 220: e202010034 (2021).
 
8. Ohgami N., Iizuka A., Hirai H., Yajima I., Iida M., Shimada A., Tsuzuki T., Jijiwa M., Asai N., Takahashi M. and Kato M.
  Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome.
  J. Biol. Chem. 296: 100389 (2021).
 
9. Isomura H., Taguchi A., Kajino T., Asai N., Nakatochi M., Kato S., Suzuki K., Yanagisawa K., Suzuki M., Fujishita T., Yamaguchi T.,
     Takahashi M. and Takahashi T.
Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development
     and identifies novel HIF-1α regulator.
Cancer Sci. 112: 1614-1623 (2021).
 
10. Nakamichi E., Sakakura H., Mii S., Yamamoto N., Hibi H., Asai M. and Takahashi M.
   Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
   Oral Dis. 27: 439-447 (2021).
 
11. Hagiwara S., Sasaki E., Hasegawa Y., Suzuki H., Nishikawa D., Beppu S., Terada H., Sawabe M., Takahashi M. and Hanai N.
    Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.  
       Cancer Med.
10: 1335-1346 (2021).

12. Kobayashi H., Gieniec K.A., Wright J.A., Wang T., Asai N., Mizutani Y., Ida T., Ando R., Suzuki N., Lannagan T.R.M., Ng J.Q.,
     Hara A., Shiraki Y., Mii S., Ichinose M., Vrbanac L., Lawrence M.J., Sammour T., Uehara   K., Davies G., Lisowski L.,
     Alexander I.E., Hayakawa Y., Butler L.M., Zannettino A.C.W., Din M.O., Hasty J., Burt A.D., Leedham S.J., Rustgi A.K.,
     Mukherjee S., Wang T.C., Enomoto A., Takahashi M., Worthley D.L. and Woods S.L.
 
     The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
   
     Gastroenterology
160: 1224-1239 (2021).

13.Mihara K(12人省略、10番目). Effectiveness of 4-1BB-costimulated HER2-targeted chimeric receptor T cell therapy for synovial sarcoma. Transl Oncol. 2021 14(12):101227.


2020年

1.  Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S. 
      and Takahashi M.The Daple-CK1ε complex regulates Dvl2 phosphorylation and canonical Wnt 
      signaling.Biochem Biophys Res Commun. 532:406-413 (2020).

2.  Chen C, Enomoto A, Weng L, Taki T, Shiraki Y, Mii S, Ichihara R, Kanda M, Koike M, 
  Kodera Y. and Takahashi M.Complex roles of the actin-binding protein Girdin/GIV in DNA 
     damage-induced apoptosis of cancer cells.Cancer Sci. 111: 4303-4317 (2020).

3.  Taki T, Shiraki Y, Enomoto A, Weng L, Chen C, Asai N, Murakumo Y, Yokoi K, Takahashi M. 
      and Mii S.CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β 
  signaling.Cancer Sci. 111: 4616-4628 (2020).
 
4.  Takagishi M, Esaki N, Takahashi K. and Takahashi M.Cytoplasmic Dynein Functions in 
  Planar Polarization of Basal Bodies within Ciliated Cells.iScience 23:101213 (2020).
 
5.  Iida M, Tazaki A, Yajima I, Ohgami N, Taguchi N, Goto Y, Kumasaka Y.M, Prevost-BlondelA,
  Kono M., Akiyama M., Takahashi M. and Kato M.Hair graying with aging in mice carrying 
  oncogenic RET Aging Cell 19: e13273 (2020).
 
6.  Kawai K. and Takahashi M. Intracellular RET signaling pathways activated by GDNF. Cell Tissue Res. 382:113-123 (2020).
 
7.  Takahashi M., Kawai K. and Asai N.Roles of the RET Proto-oncogene in Cancer and Development JMA J. 3: 175-181 (2020).
 
8.  Kasahara Y, Shin C, Kubo N, Mihara K, Iwabuchi H, Takachi T, Imamura M, Saitoh A, Imai C.Development and
  characterisation of NKp44-based  chimeric antigen receptors that confer T cells with NK cell-like specificity.
  Clin Transl Immunology. 2020 Jul  8;9(7):e1147. doi: 10.1002/cti2.1147. PMID: 32670576; PMCID: PMC7341825. 
 
9. Matsumura N, Sasaki N, Cho Y, Daimaru Y, Nojima T, Mizuno N, Takei Y, Mihara K. Rare 
  primary extramedullary hematopoiesis of the thyroid without
  intranodular vascularity and mutations in the JAK2, MPL, and calreticulin genes. Ann
  Hematol. 2020 Sep;99(9):2211-2213. doi: 10.1007/s00277-020-04086-3. Epub 2020 May 21. PMID: 32440789.
 
10. Mizuno N, Kume K, Nagatani Y, Matsuda S, Iwata T, Ouhara K, Kajiya M, Takeda K, Matsuda
  Y, Tada Y, Ohsawa R, Morino H, Mihara K, Fujita T,Kawaguchi H, Shiba H, Kawakami H, Kurihara H.
  Aggressive periodontitis and NOD2 variants. J Hum Genet. 2020 Oct;65(10):841-846.
    doi: 10.1038/s10038-020-0777-z. Epub 2020 May 19. PMID: 32424308. 

11. Mizuno N, Iwata T, Ohsawa R, Ouhara K, Matsuda S, Kajiya M, Matsuda Y, Kume K, Tada Y, 
    Morino H, Yoshimoto T, Ueki Y, Mihara K, Sotomaru Y, Takeda K, Munenaga S, Fujita T, 
    Kawaguchi H, Shiba H, Kawakami H, Kurihara  H. Optineurin regulates osteoblastogenesis
    through STAT1. Biochem Biophys Res Commun. 2020 May 14;525(4):889-894. doi: 10.
    1016/j.bbrc.2020.03.028. Epub 2020 Mar 12. PMID:32171527